What is Sermorelin?
Sermorelin is a synthetic 29-amino acid peptide that represents the active amino-terminal fragment of natural Growth Hormone-Releasing Hormone (GHRH 1-44). It is the shortest fully functional fragment of GHRH. Sermorelin was developed as a clinical tool to stimulate the pituitary gland's natural production of growth hormone.
How does Sermorelin work?
Sermorelin binds to GHRH receptors on somatotropic cells in the anterior pituitary gland. This stimulates these cells to synthesize and secrete endogenous human Growth Hormone (hGH) in a pulsatile manner. Because it acts on the pituitary rather than replacing GH directly, Sermorelin preserves the body's natural negative feedback loop, preventing the risk of growth hormone overdose or pituitary shutdown.
Primary Documented Uses
- Treatment of adult-onset Growth Hormone Deficiency (GHD)
- Promoting healthy aging, muscle retention, and fat loss
- Improving deep sleep and physical recovery
- Diagnosing pituitary function in clinical settings
Research Summary
Sermorelin is backed by extensive human clinical data. It has been shown to effectively treat growth hormone deficiency in children and age-related GH decline in adults. Clinical benefits include increased lean muscle mass, reduced body fat, improved skin elasticity, enhanced bone mineral density, and better sleep quality. It is widely considered a safer, more physiological alternative to synthetic hGH therapy.
Legal and Regulatory Status
Sermorelin is FDA-approved for the treatment of growth hormone deficiency. It is a prescription-only medication. Unlike many other GHRH analogs (which are restricted), Sermorelin is widely and legally compounded by qualified 503A compounding pharmacies for prescription use.
Frequently Asked Questions
What is Sermorelin?
Sermorelin is An FDA-approved synthetic GHRH fragment used clinically to diagnose and treat growth hormone deficiency in children and adults.
How does Sermorelin work?
Sermorelin binds to GHRH receptors on somatotropic cells in the anterior pituitary gland. This stimulates these cells to synthesize and secrete endogenous human Growth Hormone (hGH) in a pulsatile manner. Because it acts on the pituitary rather than replacing GH directly, Sermorelin preserves the body's natural negative feedback loop, preventing the risk of growth hormone overdose or pituitary shutdown.
What does research say about Sermorelin?
Sermorelin is backed by extensive human clinical data. It has been shown to effectively treat growth hormone deficiency in children and age-related GH decline in adults. Clinical benefits include increased lean muscle mass, reduced body fat, improved skin elasticity, enhanced bone mineral density, and better sleep quality. It is widely considered a safer, more physiological alternative to synthetic hGH therapy.
Is Sermorelin FDA-approved or legally available?
Sermorelin is FDA-approved for the treatment of growth hormone deficiency. It is a prescription-only medication. Unlike many other GHRH analogs (which are restricted), Sermorelin is widely and legally compounded by qualified 503A compounding pharmacies for prescription use.